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Inflammatory signaling is restricted through degrada-
tion and the translational repression of cytokine
mRNAs.A key factor in this regulation is tristetraprolin
(TTP), an RNA-binding protein (RBP) that recruits
RNA-destabilizing factors and the translation inhibi-
tory complex 4EHP-GIGYF1/2 to AU-rich element
(ARE)-containing mRNAs. Here, we show that the
RBPZNF598contributes to the same regulatorymod-
ule in a TTP-like manner. Similar to TTP, ZNF598
harbors three proline-rich motifs that bind the GYF
domain of GIGYF1. RNA sequencing experiments
showed that ZNF598 is required for the regulation of
known TTP targets, including IL-8 and CSF2 mRNA.
Furthermore, we demonstrate that ZNF598 binds to
IL-8 mRNA, but not TNFmRNA. Collectively, our find-
ings highlight that ZNF598 functions as an RBP that
buffers the level of a range of mRNAs. We propose
that ZNF598 is a TTP-like factor that can contribute
to the regulation of the inflammatory potential of cyto-
kine-producing cells.
INTRODUCTION
Multi-layered posttranscriptional regulation of gene expression
allows for rapidcellular transitionsandadaptation todiversestim-
uli (Gerstberger et al., 2014). The production of cytokines and
other inflammatory mediators by immune cells is regulated
through these mechanisms, a key example being the destabiliz-
ingeffectoncytokine transcriptsexertedby theRNA-bindingpro-
tein tristetraprolin (TTP/ZFP36/TIS11) (Clark and Dean, 2016;Cell R
This is an open access article undTiedje et al., 2014). TTP interacts with the decapping factor
DCP2 (Fenger-Grøn et al., 2005), the CNOT1 subunit of the
CCR4-NOT deadenylase complex (Fabian et al., 2013; Sandler
et al., 2011), and the RNA-degrading exosome (Chen et al.,
2001; Lykke-Andersen and Wagner, 2005). By recruiting these
destabilizing activities, TTP mediates the rapid turnover of client
mRNAs. TTP contains two RNA-binding zinc fingers that recog-
nize adenylate-uridylate AU-rich elements (AREs) in the 30 UTR
of sensitive transcripts (Clark and Dean, 2016). When encoun-
tering inflammatory activators, this repressivemechanism is alle-
viated through the action of the p38/MK2 signaling axis and TTP
phosphorylation, allowing for the rapid increase in mRNAs
copies, which for some targets like that encoding TNF can be
massive (Tiedje et al., 2014). This inactivation critically requires
two MK2 phosphorylation sites on TTP, which mediates interac-
tion with 14-3-3 proteins (Stoecklin et al., 2004; Tiedje et al.,
2016). The binding of 14-3-3 may directly prevent the binding of
TTP to mRNAs, the recruitment of destabilizing activities to the
complex, or a combination of the two. As a direct consequence
of its role as a suppressor of inflammatory signaling, loss of TTP
inmice results in constitutively elevated levels of circulating cyto-
kines and chronic inflammation (Taylor et al., 1996).
4EHP (EIF4E2) is an ortholog of the mRNA cap-binding and
translation initiation factor EIF4E1, which is defective for binding
to EIF4G and thus cannot assemble into a productive EIF4F initi-
ation complex (Rom et al., 1998; Zuberek et al., 2007). As a
result, 4EHP-bound mRNAs are translationally silenced, and
this mechanism is required for perinatal viability in mice (Morita
et al., 2012). 4EHP forms complexes with the GYF domain-
containing proteins GIGYF1 and GIGYF2, which are critical
for this translational repression (Peter et al., 2017). It has been
proposed that GIGYFs act as scaffolds that link mRNA-binding
proteins with 4EHP, providing target specificity in translational
silencing. TTP is one such specificity factor, and at least parteports 26, 3511–3521, March 26, 2019 ª 2019 The Author(s). 3511
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Figure 1. GIGYF1 Binds ZNF598 and TTP via
GYF Domains
(A) U2OS cells were transfected with FLAG-
ZNF598 plasmid. Lysates were treated with RNase
A as indicated and subjected to FLAG immuno-
precipitation, followed by immunoblotting with
antibodies against GIGYF1, GIGYF2, and ZNF598.
(B) Schematic representation of GYGIF1 domain
structure and GFP-tagged truncation constructs
used in (C).
(C) U2OS cells were co-transfected with FLAG-
ZNF598 construct and plasmids encoding GFP-
GIGYF1 fragments from (B). Lysatesweresubjected
to GFP immunoprecipitation followed by immuno-
blotting with antibodies against FLAG and GFP.
(D) U2OS cells were transfected with indicated
siRNAs, and WT or mutant versions of GFP-GI-
GYF1 plasmid. Lysates were treated as in (C) and
also blotted for actin.
(E) As in (D), except that cells were transfected
with TTP siRNA and lysates were analyzed by
immunoblotting with TTP antibody.of the repression of pro-inflammatory gene expression occurs in
the context of a 4EHP-GIGYF2-TTP complex (Fu et al., 2016; Tao
and Gao, 2015). Apart from serving as mere scaffolding factors,
GIGYF1/2 may also contribute directly to the translational
repression of transcripts (Amaya Ramirez et al., 2018; Peter
et al., 2017). GYF domains have high affinity for polyproline
stretches, a feature shared with other protein-protein interaction
domains such as the SH3 family (Kofler et al., 2009). TTP con-
tains three proline clusters, and these are required for integrating
TTP into the complex with 4EHP and GIGYF2 (Fu et al., 2016).
During the process of protein translation, the stalling of ribo-
somes triggers a conserved salvage pathway that disassembles
these ribosomes and mediates ubiquitination, release, and
degradation of the nascent peptide chain (Joazeiro, 2017). A
large body of recent work identified the Saccharomyces cerevi-
siae ubiquitin ligase Hel2 and its mammalian counterpart
ZNF598 as early responders in ribosome-associated quality
control (RQC) (Garzia et al., 2017; Juszkiewicz and Hegde,
2017; Sundaramoorthy et al., 2017).
In previous work that uncovered translational repression by
4EHP and GIGYF proteins, ZNF598 was also found to be asso-
ciated with these complexes (Morita et al., 2012). Similar to
TTP, ZNF598 contains RNA-binding zinc fingers; we therefore
investigated whether this protein could also have the potential
for posttranscriptional gene regulation. Here, we show that3512 Cell Reports 26, 3511–3521, March 26, 2019ZNF598 binds GIGYF1/2 in a manner
similar to that described for TTP and
GIGYF2 (Fu et al., 2016) and that these
two RNA-binding proteins share a num-
ber of mRNA-binding partners. ZNF598
deficiency is associated with the upregu-
lation of a number of inflammation-asso-
ciated transcripts, some of which are
also regulated by TTP, including inter-
leukin 8 (IL-8) and colony-stimulating
factor 2 (CSF2) mRNA. Our results identifyZNF598 as a TTP-like factor in the posttranscriptional regulation
of the inflammatory response, in addition to its established role
in RQC.
RESULTS
GIGYF Proteins Bind ZNF598 and TTP via GYF Domains
Using co-immunoprecipitation in U2OS cells, we readily
observed a strong interaction between ZNF598 and GIGYF1
when purifying FLAG-tagged ZNF598, GFP-tagged GIGYF1,
and endogenous GIGYF1 (Figures 1A, S1A, and S1B). This
observation could be extended to several human cell lines in
which FLAG-ZNF598 co-purifiedwith bothGIGYF1 andGIGYF2,
in accordance with previous work (Figures S1C and S1E) (Morita
et al., 2012). These interactions were not mediated by RNA, as
treatment of the lysates with an RNase A before immunoprecip-
itation did not ablate the binding (Figures 1A and S1C). By gener-
ating and analyzing a series of overlapping and N-terminally
GFP-tagged fragments and deletion constructs of GIGYF1, we
narrowed down the region responsible for ZNF598 binding to a
fragment comprising the GYF domain (Figures 1B and 1C). We
then proceeded to disable this domain in the context of full-
length GIGYF1, either by deletion of the three signature amino
acids (DGYF) or by single mutation of the phenylalanine (mutant
F504A). These alterations completely abolished ZNF598 binding,
Figure 2. Architecture of 4EHP-GIGYF-RBP Complexes
(A) Domain structure of TTP and ZNF598. Notice the presence of zinc fingers (C3H1 and C2H2 types) and polyproline stretches in both proteins.
(B) Alignment of polyproline stretches from ZNF598 and TTP across species. H, Homo; P, Pan; C, Canis; B, Bos; M, Mus; R, Rattus; G, Gallus; X, Xenopus; and D,
Danio.
(C) U2OS cells were transfected with indicated siRNAs and WT or proline-to-alanine substitution mutant versions of GFP-ZNF598 plasmid. Lysates
were subjected to GFP immunoprecipitation, followed by immunoblotting with antibodies against GIGYF1, GFP, and minichromosome maintenance complex 6
(MCM6). WCE, whole-cell extract; IP, immunoprecipitation.
(legend continued on next page)
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strongly suggesting that the GYF domain of GIGYF1 constitutes
the ZNF598 binding domain (Figure 1D). It was recently sug-
gested, although not formally proven, that the same domain is
responsible for TTP interaction by contacting the signature
proline stretches in this protein, and it was also shown that
GYF and related domains have high affinity for such proline
stretches (Fu et al., 2016; Kofler et al., 2009). We were able
to corroborate these findings by showing that the above-
mentioned GYF domain mutants of GIGYF1 were completely
defective for TTP binding (Figures 1E and S1D).
Given the overlapping requirements of the GIGYF1 GYF
domain for binding to both ZNF598 and TTP, we analyzed the
amino acid sequence of ZNF598 for the presence of polyproline
stretches. We spotted three such clusters in the C-terminal half
of ZNF598, which were conserved all the way to zebrafish, and
even in the surrounding amino acids they bear a strong resem-
blance to the polyproline stretches in TTP (Figures 2A and 2B).
When the last three prolines in each of these clusters were
mutated to alanines, the binding of ZNF598 to GIGYF1 and
GIGYF2 was completely abolished (Figures 2C and S1E). The
same strict requirement for the polyproline stretches in TTP for
interaction with GIGYF proteins was shown recently (Fu et al.,
2016), and together with our own observations, suggests that
ZNF598 and TTP have remarkable structural similarities and
display equivalent modes of interaction with GIGYF proteins.
Hierarchical Complex Formation between 4EHP,
GIGYF1, and RNA-Binding Factors TTP and ZNF598
To further characterize the architecture of GIGYF-containing
complexes, we performed a series of pull-down experiments.
When purifying FLAG-tagged 4EHP, we readily detected interac-
tions with endogenous GIGYF1 and GIGYF2, in full agreement
with the published literature (Morita et al., 2012; Peter et al.,
2017). These interactions appeared to be independent, as
GIGYF2 was not required for the interaction of GIGYF1 with
4EHP and vice versa (Figure 2D). In fact, while both GFP-GIGYF1
and GFP-GIGYF2 readily co-purified FLAG-4EHP, we could not
detect any co-purification of GIGYF2 and GIGYF1, suggesting
that these two proteins form independent complexes with
4EHP (Figures S1F and S1G).
The primary sequence of ZNF598 reveals the presence of
potential RNA-binding domains. In fact, in addition to the anno-
tated C2H2-type zinc finger in its N-terminal half (Figure 2A),
putative zinc finger domains can be spotted throughout the
sequence of ZNF598 (Garzia et al., 2017). We thus surmised
that, similar to TTP, ZNF598 could be an RNA-binding protein,(D) U2OS cells were transfected with indicated siRNAs and FLAG-4EHP plasmi
noblotting with antibodies against GIGYF1, GIGYF2, FLAG, and MCM6. Asterisk
(E) U2OS cells inducibly expressing GFP-ZNF598 were induced with doxycyclin
ZNF598 was immobilized on GFP beads, treated with increasing amounts of RN
(PNK) in the presence of radioactive ATP. The material was released from the b
membrane. Radioactive signals were measured by autoradiography. Input samp
GFP antibodies.
(F) U2OS cells were transfected with the indicated plasmids, cross-linked with a
proteins were immobilized on beads, treated with either a high or a low concentra
radioactive ATP. Thematerial was released from the beads by boiling, separated b
were measured by autoradiography. GFP-RBM7 was used as positive control.
3514 Cell Reports 26, 3511–3521, March 26, 2019and we addressed this by cross-linking immunoprecipitation
(CLIP) experiments (Ko¨nig et al., 2012). In support of our hypoth-
esis, GFP-ZNF598 co-purified RNA from UV-cross-linked cells,
resulting in a smear of radioactivity-labeled bands running
above the expected molecular weight of GFP-ZNF598. Treat-
ment of the cross-linked extracts with increasing amounts of
RNase gradually collapsed these bands to the expected molec-
ular weight of GFP-ZNF598, suggesting that ZNF598 directly
binds RNA species in cells (Figure 2E). Together with the previ-
ous results, these findings suggest the existence of hierarchical
and mutually exclusive complexes between the cap-binding
protein 4EHP, scaffolding factors GIGYF1 and GIGYF2, and
RNA-binding proteins (RBPs) such as TTP, ZNF598, and poten-
tially others, each with the potential to regulate translation
and/or turnover of specific transcripts. We also used the
CLIP approach combined with the purification of GIGYF1 and
GIGYF2, but in neither case did we observe a radioactive
signal to indicate direct RNA interaction of these factors.
Conversely, 4EHP and the control RNA-binding motif 7 (RBM7)
(Lubas et al., 2015) strongly cross-linked to RNA under these
experimental settings, suggesting to us that RNA-binding activ-
ity within these complexes is restricted to 4EHP, TTP, and
ZNF598 (Figure 2F).
ZNF598 Suppresses Inflammation-Associated mRNAs
To elucidate a potential role for ZNF598 in posttranscriptional
gene regulation, we proceeded to perform RNA sequencing
(RNA-seq) from cell extracts. We used standard methods to pro-
duce four cDNA sequencing libraries in independent biological
duplicates from cells transfected with either a mismatch control
or ZNF598-targeting small interfering RNA (siRNA) and incu-
bated or not with IL-1b for 1 h (Figures 3A and S2A). Sequencing
of the eight libraries each resulted in approximately 50 million
reads that could bemapped to the genome and formed the basis
for differential expression analysis. This revealed the existence of
a substantial number of transcripts, the abundances of which
were sensitive to ZNF598 depletion under resting and IL-1b stim-
ulation conditions (Figure 3B; Table S1). By determining the over-
lap of ZNF598-regulated genes under these two conditions, it
became clear that >50% of all deregulated genes are decoupled
from IL-1b stimulation (Figure 3B). Furthermore, we realized that
many genes exclusively deregulated under resting conditions
(317) are associated with inflammation (Figure S2B), pointing
toward amode of action similar to TTP. Almost 40%of all targets
induced by IL-1b stimulation in control cells are part of this
subset of transcripts (Figure 3C). We proceeded to conduct ad. Lysates were subjected to FLAG immunoprecipitation, followed by immu-
denotes unspecific band.
e (dox) for 12 h, treated with UV-C (175 J/m2), and immediately lysed. GFP-
ase A, and subjected to phosphorylation by polynucleotide 50-hydroxyl kinase
eads by boiling, separated by SDS-PAGE, and blotted onto a nitrocellulose
les were transferred onto a nitrocellulose membrane and immunoblotted with
high dose of UV-C (175 J/m2) and immediately lysed. GFP- and FLAG-tagged
tion of RNase, and subjected to phosphorylation by T4-PNK in the presence of
y SDS-PAGE, and blotted onto a nitrocellulose membrane. Radioactive signals
Figure 3. RNA-Seq Reveals Regulation of Inflammatory Transcripts by ZNF598
(A) Experimental setup for total RNA-seq. U2OS cells were transfected with the indicated siRNAs and stimulated with IL-1b for 1 h, as indicated (2 biological
replicates). Cells were lysed, and the RNA was isolated and converted to barcoded cDNA libraries that were subjected to sequencing.
(legend continued on next page)
Cell Reports 26, 3511–3521, March 26, 2019 3515
pathway overrepresentation analysis for these overlapping
transcripts (Figure 3D) and for the ZNF598-sensitive transcripts
under resting conditions (Figure S2B) using the WebGestalt
(Zhang et al., 2005) interface. This revealed that in the absence
of ZNF598, deregulated transcripts were associated with inflam-
mation and immune signaling (Figures 3D and S2B). Since IL-1b
stimulation is known to massively upregulate inflammation-
associated RNAs (Dinarello, 2011), we next asked how strong
the deregulation by ZNF598-depletion under resting conditions
is, compared to after IL-1b stimulation. As seen in a clustered
heatmap, the depletion of ZNF598 upregulated the depicted
transcripts only moderately but consistently for this selected
group (Figure 3E). It can also be seen that the differences are
uncoupled upon IL-1b stimulation, suggesting that ZNF598
regulates inflammation-associated transcripts under resting
conditions. To further validate these findings, we depleted
ZNF598 with three additional and independent siRNAs (Fig-
ure S2C) and performed qPCR analysis for upregulated tran-
scripts from our RNA-seq experiment. Transfection of each of
these siRNAs was broadly accompanied by an increase in the
levels of inflammation-associated mRNAs (Figure 3F). Of note,
we did not observe any deregulation of TTP/ZFP36, which is
considered the master regulator of (pro)-inflammatory mRNAs
(Figure 3F). We could partially rescue these effects by transient
transfection of exogenous and siRNA-resistant ZNF598 into
ZNF598-depleted cells (Figures 3G, 3H, and S2D), allowing us
to conclude that this RBP negatively regulates the abundance
of a subset of transcripts.
Several of the ZNF598-regulated transcripts, including IL-8
and CSF2 mRNA (Figures 4A and 4B), are also established
TTP targets, and we surmised that our analysis indicated that
ZNF598, like TTP, is required for the suppression of pro-inflam-
matory signaling in resting cells. This was further underscored by
the fact that the majority of mRNAs that increased upon IL-1b
stimulation were already elevated after ZNF598 knockdown in
our RNA-seq experiment (Figures 3E, 4A, and 4B), and we thus
attempted to reproduce these effects by qPCR analysis. In these
experiments, the basal levels of IL-8 and CSF2 transcripts were
elevated in ZNF598 siRNA-treated cells, but displayed a normal
level of induction following IL-1b stimulation (Figures 4C and 4D).
We also constructed a cell line that allows for doxycycline-
induced expression of mitogen-activated protein kinase kinase
6 (MKK6) and ensuing activation of p38 and MK2 (Figures S2E
and S2F) to study the regulation of inflammatory transcripts. Un-
der these experimental conditions, IL-8 mRNA was substantially(B) Venn diagram illustrating the overlap between ZNF598-sensitive transcripts in
upregulated upon IL-1b treatment in both siCTRL and siZNF598 cells (siZNF598
(C) Venn diagram showing the overlap between IL-1b-sensitive transcripts in resti
transcripts (siZNF598 versus siCTRL, 731 transcripts).
(D) Pathway overrepresentation analysis of 57 IL-1b-induced transcripts that are
deduced with the WebGestalt tool (Zhang et al., 2005). Numbers in brackets ind
(E) Clustered heatmap of ZNF598-sensitive transcripts involved in the IL-1b-in
subsequent validation experiments.
(F) U2OS cells were transfected with four independent ZNF598 siRNAs (#2–#5). Up
mRNAs was determined by qPCR. Black dots indicate individual measurements
(G) U2OS cells were transfected with indicated siRNAs and siRNA-resistant GFP-
of IL-8 mRNA was determined by qPCR. Black dots indicate measurements of t
(H) Lysates from (G) were analyzed by immunoblotting with antibodies against Z
3516 Cell Reports 26, 3511–3521, March 26, 2019increased after MKK6 induction in an MK2-dependent manner.
While not required for this reaction, siRNA-mediated depletion
of ZNF598 was accompanied by increased basal levels of
IL-8 transcript (Figure S2F). Finally, we compared the sensitivity
of the above transcripts to TTP and ZNF598 depletion, respec-
tively. These interventions led to a comparable elevation of
IL-8 and CSF2 mRNA levels, confirming that they are targets
for TTP-mediated degradation and that, at least in U2OS
cells, they are controlled to a similar degree by both RBPs (Fig-
ures 4E and 4F). ZNF598 may regulate mRNA abundance in a
manner similar to TTP, and at least for IL-8 and CSF2 mRNA,
ZNF598 knockdown decreased the turnover rate upon actino-
mycin D-induced transcriptional blockade (Figure S2G). Our
RNA-seq experiments also revealed known TTP targets such
as tumor necrosis factor (TNF) mRNA that were not sensitive
to ZNF598 depletion, yet still enhanced upon IL-1b stimulation
(Figure S3A). These experiments highlight the existence of a
ZNF598-regulated transcript pool that is associated with inflam-
matory signaling and partly overlapping with the TTP-sensitive
transcriptome.
ZNF598 Binds to IL-8 mRNA
Our data suggest that ZNF598, similar to TTP, is involved in the
regulation of inflammatory transcripts in the context of 4EHP-GI-
GYF1/2-ZNF598 complexes. To corroborate our findings, we
used RNA immunoprecipitation (RIP) to detect associations
between ZNF598 and specific transcripts. We purified GFP-
ZNF598 and GFP-TTP from cell lysates and probed the associ-
ated RNA content by qPCR for the presence of IL-8 transcript,
the abundance of which we found to be regulated by both
ZNF598 and TTP (Figure 4E). Even though this transcript is pre-
sent in very small amounts in unstimulated cells (Winzen et al.,
1999), we were able to reliably amplify it from both the GFP-
ZNF598 andGFP-TTP associated RNA pool (Figure 5A), produc-
ing amplicons of the expected molecular weight (Figure 5B).
Conversely, TNF mRNA, the levels of which were not regulated
by ZNF598 but were increased upon IL-1b stimulation (Fig-
ure S3A), could only be amplified from TTP pull-downs (Figures
5A and 5B), underscoring the partial nature of the overlap
between TTP and ZNF598 client mRNAs. To further characterize
the RNA-binding properties of ZNF598, we used an RNA-elec-
trophoretic mobility shift assay (REMSA) strategy. We purified
strep-ZNF598 and strep-TTP from HEK293T cells (Figures
S4A–S4C) and evaluated the ability of these proteins to induce
a mobility shift of a 60-base fragment of the 30 UTR of IL-8non-stimulated cells (siZNF598 versus siCTRL, 731 transcripts) and transcripts
+ IL-1b versus siCTRL + IL-1b, 779 transcripts).
ng cells (siCTRL + IL-1b versus siCTRL, 154 transcripts) and ZNF598-sensitive
constitutively upregulated in ZNF598-depleted cells (overlapping area in C),
icate the number of genes enriched clustering to the corresponding pathway.
duced inflammatory response. Transcripts highlighted in red were used for
on cell lysis, total RNAwas recovered, and the relative abundance of indicated
; bars indicate the means ± SDs from 3–5 technical replicates.
ZNF598. Upon cell lysis, total RNA was recovered, and the relative abundance
hree biological replicates. Bars indicate means ± SDs.
NF598 and GFP.
A C E
B D F
Figure 4. ZNF598 and TTP Control the Abundance of IL-8 and CSF2 Transcripts
(A) Mapping of sequencing reads to the IL-8 gene from two biological replicates of the experiment outlined in Figure 3A. Note the difference in scale used for mock
versus IL-1b-treated samples. IL-8 transcript structure is indicated below the profiles. The arrow denotes the location of the start codon, and the increasing
thickness of the line represents introns, untranslated regions, and exons, respectively.
(B) As in (A), except that reads were mapped to the CSF2 gene.
(C) U2OS cells were transfected with siRNAs and treated with IL-1b (1 h), as indicated. Upon cell lysis, total RNA was recovered, and the relative abundance of
IL-8 mRNA was determined by qPCR. Red dots indicate measurements from two biological replicates. Bars indicate the means.
(D) As in (C), except that CSF2 mRNA abundance was measured.
(E) U2OS cells were transfected with indicated siRNAs. Upon cell lysis, total RNA was recovered, and the relative abundance of IL-8 mRNA was determined by
qPCR. Red dots indicate the measurements from three biological replicates.
(F) As in (E), except that CSF2 mRNA abundance was measured.mRNA, which was previously annotated as the minimal TTP-
binding region (Figure 5C) (Winzen et al., 2007). In both cases,
pre-incubation with increasing amounts of protein resulted in
the gradual depletion of free RNA probe and recovery of the fluo-
rescence signal in amobility-retarded form, which is indicative of
an RNA-protein complex. Quantification of the band intensities
indicated a similar affinity of the two RBPs toward the RNA probe
(Figure 5D). These results indicate that ZNF598, like TTP, can
bind the 30 UTR of IL-8, even in an in vitro setting. The interactionis likely to be direct, as the mutant of ZNF598 that cannot asso-
ciate with the 4EHP-GIGYF module (9P-9A) bound the probe
with similar affinity (Figures 5E, S4D, and S4E); however, we
cannot formally exclude the possibility that these interactions
are mediated by factors co-purifying with wild-type (WT) and
mutant GFP-ZNF598. We also used this assay to evaluate the
contribution of the different RNA-binding regions in ZNF598 to
IL-8 mRNA binding. Our deletion analysis indicated that both
N- and C-terminal sequences in ZNF598 are involved in RNACell Reports 26, 3511–3521, March 26, 2019 3517
Figure 5. ZNF598 Binds Directly to IL-8
Transcript
(A) U2OS cells were transfected with indicated GFP
plasmids, lysed, and subjected to GFP immuno-
precipitation. RNA species were reclaimed from the
beads, converted to cDNA, and analyzed by qPCR,
with primers against IL-8 and TNF. Ct, cycle
threshold.
(B) Input RNA and qPCR-amplified material from
(A) were separated on agarose gels and stained for
DNA content, producing PCR fragments of the
expected sizes. Input lysates were analyzed by
immunoblotting, with antibodies against GFP and
MCM6. WB, western blot.
(C) A fluorescently tagged RNA fragment
comprising 60 bases from the IL-8 30 UTR was
incubated with increasing amounts of purified
strep-TTP (left) or strep-ZNF598 (right). Reaction
mixtures were separated by gel electrophoresis
under non-denaturing conditions and fluorescent
signals recorded. 6’FAM, 6-carboxyfluorescein.
(D) Estimation of ZNF598 and TTP affinity toward
the IL-8 30 UTR probe was calculated based on
fluorescence signal of the bands in (C), and the
protein concentrations were estimated from Fig-
ure S4C. Data points represent the mean of two
biological replicates for ZNF598 and TTP.
(E) As in (C), except that the IL-8 probe was
incubated with deletion constructs and mutants of
strep-tagged ZNF598.
(F) As in (C), except that purified strep-TTP and
strep-ZNF598 were incubated with RNA probes
from the 30 UTR of TNF (top) or a polyA probe
(bottom).
(G) Strep-TTP and strep-ZNF598 were incubated
with the IL-8 probe and an excess of bacterial
ribosomal RNA, as indicated. Reaction mixtures
were analyzed as in (C).binding (Figures 5E, S4D, and S4E), which is in agreement with
previous publications (Garzia et al., 2017). To test whether the
RNA interaction of ZNF598 is target specific, we performed the
same experiments with the 30 UTR ARE from TNF as a probe.
Only TTP incubation resulted in a mobility shift of this probe
(Figure 5F, top), which is consistent with our RIP experiments
(Figures 5A and 5B). Furthermore, and serving as an important
control, neither ZNF598 nor TTP bound strongly to a polyA probe
(Figure 5F, bottom). The lack of a clear and unique determinant
for RNA binding in ZNF598 (Figure 5E) prompted us to further
characterize the RNA-binding properties of ZNF598 and TTP.
While TTP displays a strong preference for 30 AREs both in vivo
and in vitro, photo-activatable ribonucleoside (PAR)-CLIP anal-
ysis suggested that ZNF598 has no such preference and binds
to several species of RNA and in coding and noncoding regions3518 Cell Reports 26, 3511–3521, March 26, 2019of mRNAs (Garzia et al., 2017). This lack
of sequence stringency was underscored
by the fact that we could compete out
the binding of ZNF598 to the IL-8 probe
with high amounts of bacterial ribosomal
RNA, while under the same conditions,
TTP remained bound to its target RNA(Figure 5G). These results indicate that, although they may share
a number ofmRNA targets, ZNF598 and TTP differ greatly in their
modes of RNA interaction.
Overlap between ZNF598-Regulated and -Interacting
RNAs
Taking advantage of a recently published ZNF598 PAR-CLIP
dataset (Garzia et al., 2017), we also assessed to what degree
ZNF598 interacting transcripts were sensitive to ZNF598 deple-
tion in our RNA-seq experiments (Figure S5A). To this end, we
compared our set of strongest (log2-fold >1 and <1) and signifi-
cant (p-adj % 0.05) ZNF598-sensitive transcripts in U2OS cells
to the mRNAs significantly enriched in the PAR-CLIP dataset
(with the potential caveat that these data were generated from
HEK293T cells). This analysis indicated that roughly 10% of
the ZNF598-sensitive transcripts are also PAR-CLIP targets of
ZNF598 (Figure S5A; Table S2). Of note, when we compared
the same set of ZNF598-sensitive targets to a list of TTP interac-
tors identified by PAR-CLIP in HEK293T (Mukherjee et al., 2014),
the overlap was only 2% (data not shown). Furthermore, when
narrowing our analysis to transcripts that were detected both
in our RNA-seq experiments in U2OS cells and the previously
published ZNF598 PAR-CLIP dataset from HEK cells, we
observed that 66.6% of the transcripts showing a high CLIP
occupancy (>95th percentile) were sensitive to ZNF598 deple-
tion (Figures S5B and S5C; Table S3).
Our results suggest that ZNF598, like TTP, functions as an
RBP in a complex with 4EHP and GIGYFs, which confers post-
transcriptional control over a subset of inflammation-associated
transcripts.
DISCUSSION
In this study, we have uncovered a role for ZNF598 in posttran-
scriptional gene regulation. ZNF598 is an RBP with the capacity
to directly interact with rRNA as well as mRNA species, a subset
of which encodemediators of inflammatory signaling. The deple-
tion of ZNF598 was associated with the upregulation of a broad
range of inflammation-associated mRNAs, including the IL-8
transcript, for which we could also demonstrate direct binding
to ZNF598. We also highlighted how ZNF598 and TTP share a
number of structural features such as polyproline stretches
that bind the GYF domain of GIGYF proteins and integrate these
RBPs into larger 4EHP-GIGYF1/2-RBP translation initiation
inhibitory complexes. There is an overlap between the mRNAs
that are targeted by ZNF598 and TTP (e.g., IL-8, CSF2 mRNA).
TNF mRNA, however, appears to be a unique TTP target that
is neither bound nor regulated by ZNF598. Besides functionally
separating ZNF598 and TTP, the lack of TNF mRNA stabilization
upon ZNF598 depletion also signifies that the induction of other
inflammatory markers is not merely a TTP-dependent response
to our experimental interventions. While TTP predominantly
binds ARE sequences in the 30 UTR, ZNF598 binding sequences
appear both to be more cryptic in nature and can be located in
coding and noncoding regions of mRNAs. ZNF598 binding to
target RNAs correlates with their regulation at the mRNA level
to a certain extent.
In the case of TTP, the mechanisms governing target repres-
sion have been the subject of a number of studies (Clark and
Dean, 2016). On the one hand, TTP mediates the rapid turnover
of client mRNAs in resting cells, and this mechanism is abro-
gated upon inflammatory stimuli in a manner dependent on
MK2-mediated phosphorylation and ensuing 14-3-3 binding of
TTP (Clark and Dean, 2016; Stoecklin et al., 2004; Tiedje et al.,
2016). On the other hand, TTP confers negative translational
control over mRNAs in the context of the 4EHP-GIGYF complex
(Fu et al., 2016; Peter et al., 2017; Tao and Gao, 2015). How
ZNF598 regulates target mRNAs acting within and outside the
inflammatory response remains to be investigated in detail, but
also in this case, the mechanism is likely to involve the destabi-
lization of client mRNAs and translational repression. We could
show that the half-life of IL-8 and CSF2 transcripts is enhanced
in the absence of ZNF598.The ubiquitin ligase function of mammalian ZNF598 was
recently shown to be critically required for ribosome ubiquitina-
tion and RQC (Garzia et al., 2017; Juszkiewicz and Hegde,
2017; Sundaramoorthy et al., 2017). This function is conserved
from its distant S. cerevisiae homolog Hel2. Of note, TTP and
GIGYF1/2 do not have budding yeast homologs, and when we
inspected the primary structure of Hel2, we did not observe a
conservation of the polyproline stretches that in mammalian
ZNF598 bind GIGYF1/2. This suggests to us that the posttran-
scriptional gene regulatory function of ZNF598, or at least its
integration into translation inhibitory complexes, is amore recent
evolutionary invention that likely coincided with the appearance
of the GIGYF proteins. In this context, it is interesting that only a
small part of the cellular pool of ZNF598 associates with trans-
lating ribosomes, and that deletion mutants defective for ribo-
some binding still retain the ability to bind RNA (Garzia et al.,
2017). Such results support our proposal of an additional role
for ZNF598, in addition to its established function during RQC.
Our data establish ZNF598 as a posttranscriptional regulator
of gene expression and suppressor of inflammatory signaling.
Whether this role of ZNF598 has implications for the function
of the immune system and/or human health remains to be
established. Efforts toward this end will be hampered by the
likely profound defects associated with a compromised RQC,
and the establishment of separation-of-function mutants of
ZNF598 will be crucial to initiate such studies. In conclusion,
our findings significantly add to the present knowledge of regu-
latory mechanisms that control inflammatory signaling in cells.
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Rabbit polyclonal anti-GIGYF1 Abcam Cat # 121784; RRID: AB_11130603
Mouse monoclonal anti-GIGYF2 (A-12) Santa Cruz Biotechnology Cat # sc-393918
Rabbit polyclonal anti-ZNF598 Sigma Aldrich Cat # HPA041760; RRID: AB_10794787
Rabbit polyclonal anti-TTP Sigma Aldrich Cat # T5327; RRID: AB_1841222
Rabbit monoclonal anti-MK2 Cell Signaling Cat # 3042; RRID: AB_2141314
Mouse monoclonal anti-GFP (7.1) Roche Cat # 11814460001; RRID: AB_390913
Mouse monoclonal anti-FLAG (M2) Sigma-Aldrich Cat # F1804; RRID: AB_262044
Goat polyclonal anti-MCM6 Santa Cruz Biotechnology Cat # sc-9843; RRID: AB_2142543
Rabbit monoclonal anti-PKM2 XP (D784A) Cell Signaling Cat # 4053; RRID: AB_1904096
Mouse monoclonal anti-Actin (C4) Millipore Cat # MAB1501; RRID: AB_2223041
Rabbit polyclonal anti-His-probe (H-15) Santa Cruz Biotechnology Cat # sc-803; RRID: AB_631655
Chemicals, Peptides, and Recombinant Proteins
Doxycycline Sigma-Aldrich Cat # D3347
Interleukin-1 beta Peprotech Cat # 200-01B
Actinomycin D Cayman Chemical Cat # 50-76-0
GFP-Trap magnetic agarose Chromotek Cat # gtma_20
FLAG-M2 agarose Sigma-Aldrich Cat # A2220
RNase A Thermo Fisher Scientific Cat # EN0531
RNase I Thermo Fisher Scientific Cat # EN0602
RNase A (DNase-free) Roche Cat # 11119915001
DNase I Ambion/Thermo Fisher Scientific Cat # AM2238
SUPERase,IN RNase Inhibitor Thermo Fisher Scientific Cat # AM2696
RiboLock RNase Inhibitor Thermo Fisher Scientific Cat # EO0381
TRIzol Reagent Thermo Fisher Scientific Cat # 15596026
T4-polynucleotide kinase (T4-PNK) New England Biolabs, NEB Cat # M0201
Bacterial 16S/23S rRNA Roche Cat #10206938001
Critical Commercial Assays
RevertAid Reverse Transcriptase Thermo Fisher Scientific Cat # EP0441
SENSIFast SYBR Green No ROX qPCR mix Bioline BIO-98005
SENSIFast Probe No ROX qPCR mix Bioline BIO-86005
TaqMan Gene Expression assay for IL-8 Life Technologies Cat #4331182
SYBR Green Quantitect assay for TNF (Hs_TNF_3_SG) QIAGEN Cat #QT01079561
NEBNext Ultra II directional kit New England Biolabs, NEB Cat # E7765
NEBNext Multiplex Oligos New England Biolabs, NEB Cat # E7335
NEBNext rRNA depletion kit New England Biolabs, NEB Cat # E6310
Deposited Data
RAW and processed RNASeq data This paper GEO: GSE116126
PAR-CLIP data for ZNF598 Garzia et al., 2017 SRA: SRP095894
Experimental Models: Cell Lines
Human osteosarcoma cells (U2OS) ATCC HTB-96; RRID:CVCL_0042
Human cervical cancer cells (HeLa) ATCC CCL-2; RRID:CVCL_0030
Human embryonic kidney cells (HEK293T) ATCC CRL-111268; RRID:CVCL_1926
See Table S4 for oligonucleotide information
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Recombinant DNA
pcDNA4/TO-GFP-GIGYF1 This paper N/A
pcDNA4/TO-GFP-GIGYF2 This paper N/A
pcDNA4/TO-GFP-ZNF598 This paper N/A
pcDNA4/TO-GFP-TTP This paper N/A
pcDNA4/TO-FLAG-MKK6 This paper N/A
pcDNA3-FLAG-ZNF598 Morita et al., 2012 N/A
pcDNA3.1-His-Strep-TTP Winzen et al., 2007 N/A
pFLAG-4EHP Okumura et al., 2007 Addgene Plasmid #17342
Software and Algorithms
ImageJ version 1.50i National Institute of
Health (NIH), USA
https://imagej.nih.gov/ij
PRISM 7 GraphPad Software https://www.graphpad.com/scientific-
software/prism/
Galaxy Platform Afgan et al., 2018 https://usegalaxy.org
DESeq2 Love et al., 2014 http://www.bioconductor.org/packages/
release/bioc/html/DESeq2.html
CLAP pipeline https://github.com/simras/CLAP
Pyicos Althammer et al., 2011 https://bitbucket.org/regulatorygenomicsupf/
pyicoteo/downloads/CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Simon
Bekker-Jensen (email: sbj@sund.ku.dk).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
The following cell lines were used in this study: Human osteosarcoma cells (U2OS), human embryonic kidney (HEK293T) cells and
human cervical cancer (HeLa). They were cultured in DMEM medium supplemented with 10% fetal bovine serum, L-glutamine,
penicillin and streptomycin. All cells were cultured at 37C in a humidified incubator containing 5% CO2. The cells were obtained
from ATTC. Identifier can be found in the Key Resources Table.
METHOD DETAILS
Plasmids and siRNAs
Full length GIGYF1, GIGYF2, TTP andMKK6 cDNAwas gateway cloned into the destination vectors pcDNA4/TO/GFP and pCDNA4/
TO/FLAG. All mutations in GIGYF1 were introduced by site-directed mutagenesis using KOD DNA polymerase (Millipore) according
to the manufacturer’s instructions. pcDNA3-FLAG-ZNF598 (Morita et al., 2012) was a gift from Nahum Sonenberg (McGill University,
Quebec, Canada) and subsequently sub-cloned into pcDNA4/TO/GFP using EcoRI and XhoI restriction sites. ZNF598 9P-9A was
ordered as a synthetic gene (GeneArt) and sub-cloned into pcDNA4/TO/GFP-ZNF598 using EcoRI and XhoI restriction sites.
Strep-tagged ZNF598 was generated by amplifying the cDNA using primers flanked by EcoRI and XbaI sites and subsequent
exchange of the TTP coding sequence from pcDNA3.1-His-Strep-TTP (Winzen et al., 2007). pFLAG-4EHP was a gift from Dong-Er
Zhang (Addgene plasmid #17342, (Okumura et al., 2007)). All constructs were verified by sequencing. All plasmid DNA transfections
were done using FuGene 6 (Promega) according to the manufacturer’s protocol. siRNA transfections were carried out using
RNAiMAX (Life Technologies) following manufacturer’s protocol. For siRNA target sequences (Eurofins) used in this study, see
Table S4.
Cell culture and reagents
Human U2OS osteosarcoma cells, human embryonic kidney (HEK293T) cells and human cervical cancer (HeLa) cells were
cultured in DMEM medium supplemented with 10% fetal bovine serum, L-glutamine, penicillin and streptomycin. All cells
were cultured at 37C in a humidified incubator containing 5% CO2. To generate cell lines stably expressing GFP-GIGYF1,
GFP-GIGYF2, GFP-ZNF598, GFP-TTP and FLAG-MKK6 under a doxycycline inducible promoter, cells were co-transfectedCell Reports 26, 3511–3521.e1–e4, March 26, 2019 e2
with pcDNA4/TO/GFP-GIGYF1/GIGYF2/ZNF598/TTP or pcDNA4/TO/FLAG-MKK6 and pcDNA6/TR (Life Technologies) in a 2:1
ratio and selectedwith Zeocin and Blasticidin (5 mgml-1) for 14 days. Individual clones were picked and analyzed for GFP-GIGYF1/
GIGYF2/ZNF598/TTP or FLAG-MKK6 expression using western blot (WB) and immunofluorescence (IF) analyses. Chemicals used
were Doxycycline (1 mg ml-1), Interleukin-1 beta (2 ng ml-1, Preprotech), Actinomycin D (10 mg ml-1, Cayman Chemical) and MK2
inhibitor (MK2i) PF3644022 (10 mM, Sigma).
Immunochemical methods
GFP immunoprecipitations were performed with GFP-Trap agarose beads (Chromotek), FLAG pull-downs were performed using
FLAG-M2 agarose beads (Sigma-Aldrich). All immunoprecipitations were carried out in low-salt EBC lysis buffer (150 mM NaCl;
50 mM Tris, pH 7.5; 1 mM EDTA; 0.5% NP40). For CLIP, GFP-Trap magnetic agarose beads were utilized (Chromotek). A final
concentration of 50 mg/ml RNase A (Thermo Scientific) was used to test RNA-dependencies of protein-protein interactions. Indicated
samples were incubated on ice for 20 minutes prior to immunoprecipitations. For RNA-IP experiments, U2OS cells were transiently
transfected with pcDNA4/TO-GFP-ZNF598 or pEGFP-C1 (Clontech). 24h after transfection, the cells were lysed in low salt EBC
buffer supplemented with RiboLock RNase Inhibitor (Thermo Scientific) and subjected to GFP-immunoprecipitation as described
before. RNA was reclaimed from GFP-beads using TRIzol reagent (Thermo Scientific) according to the manufacturers protocol
and analyzed by RT-qPCR. Antibodies used in this study included the following: anti-GIGYF1 (121784, Abcam, RRID:
AB_11130603; WB 1:1000), anti-GIGYF2 (sc-393918, Santa Cruz Biotechnology; WB 1:500), anti-ZNF598 (HPA041760, Sigma
Aldrich, RRID: AB_10794787; WB 1:5000), anti-TTP (T5327, Sigma Aldrich, RRID: AB_1841222; WB: 1:500), anti-MK2 (3042, Cell
Signaling, RRID: AB_2141314; WB 1:1,000); anti-GFP (11814460001, Roche, RRID: AB_390913; WB 1:1,000), anti-FLAG-M2
(F1804, Sigma-Aldrich, RRID: AB_262044; WB 1:1,000, IF 1:500), anti-MCM6 (sc-9843, Santa Cruz, RRID: AB_2142543; WB
1:1,000), anti-PKM2 (4053, Cell Signaling, RRID: AB_1904096: WB 1:1,000), anti-His-Probe (H-15) (sc-803, Santa Cruz, RRID:
AB_631655, WB 1:1,000), anti-Actin (C4) (MAB1501, Millipore, RRID: AB_2223041, WB 1:20,000).
CLIP
CLIP protocol was modified from (Tiedje et al., 2016). In short, U2OS cells transiently transfected with GFP-GIGYF1/2, GFP-RBM7,
FLAG/GFP-ZNF598, FLAG-4EHP were washed washing with ice-cold PBS and irradiated with UV-C light (175 J m-2, BS-02 irradi-
ation chamber equipped with 254nm bulbs Gro¨bel Elektronik, Germany) and total cell extracts were obtained using lysis buffer
(50 mM Tris/HCl [pH 8.0], 150 mM NaCl, 0.5% (v/v) Triton X-100 and 1 mM EDTA) and sonication (3 times for 20 s in ice). Lysates
were cleared by centrifugation and incubated with with RNase A (For ZNF598: optimal concentration RNase A (Roche) =
1,88 3 103 units/ml and RNase I (Thermo Fischer Scientific) 1 unit/ml) and DNase I (20 units/ml, Ambion) for 3 min at 37◦C and
cooled on ice for 5 min after adding urea (final concentration 0.5 M) and SUPERase IN RNase inhibitor (40 units/ml (Thermo Fischer
Scientific). Immunoprecipitation of protein:RNA complexes was performed using FLAG-M2 beads or GFP-trap magnetic agarose
beads. Samples were washed with lysis buffer plus 0.5 M Urea (2x) and high salt-urea wash buffer (50 mM Tris/HCl [pH 8.0],
1000 mM NaCl, 0.1% (v/v) Triton X-100 and 4M Urea) (3x) and PNK wash buffer (20 mM Tris–HCl [pH 7.4], 10 mM MgCl2, 0.2%
Tween-20) (2x. Samples were labeled with g -32P-ATP using T4-PNK (New England Biolabs). Then, protein:RNA complexes were
resolved by electrophoresis (SDS-PAGE) and transferred to nitrocellulose membranes. Relative phosphorylation was assayed by
radio-blotting.
Quantitative (q)PCR
Total RNA was purified from U2OS cells using TRIzol reagent (Invitrogen) according to the manufacturer’s instructions. 350 ng of
purified RNA was used in a reverse transcriptase reaction using random hexameric primers with RevertAid reverse transcriptase
(Thermo Fisher) according to manufacturer’s protocol. The generated cDNA was diluted 5-fold and used for quantification by
qPCR (2,5ul diluted cDNA) using SensiFAST SYBR green (Bioline) or SensiFAST Probe (Bioline) mastermix according to the manu-
facturer’s protocol. For detection of IL-8 mRNA, exon junction spanning TaqMan Gene Expression Assay probes (Life Technologies
#4331182 and #4331182) were used. For detection of TNF mRNA, the Quantitect Hs_TNF_3_SG primerset (QIAGEN, QT01079561)
was used. For all other trancripts DNA oligos were used for amplification. See Table S4 for oligonucleotide information. Relative RNA
levels were calculated from DCt values compared to its respective control sample and normalized to GAPDH mRNA levels.
RNA-sequencing, mapping and differential gene expression analysis
rRNA-depleted total RNA-sequencing libraries from either siCTRL- or siZNF598-transfected cells were obtained by using the
NEBNext Ultra II directional kit in combination with the NEBNext rRNA depletion kit (New England Biolabs, NEB, USA). 500 ng of total
TRIzol-purified RNAwas used as starting material for each sample and was processed according to manufacturer’s instructions. For
the final amplification of the libraries 6 cycles were run. For each condition, biological duplicate libraries were constructed. Prior to the
75 bp single end high output run on an Illumina NEXTSeq 500 (Illumina Inc., USA) system, libraries were analyzed and quantifiedwith a
Fragment Analyzer (Advanced Analytical Technologies, Inc., USA) and consequently multiplexed. The resulting RAW reads were
demultiplexed and converted to the FASTQ format and groomed (FASTQ Groomer) before adaptor- and quality-trimming using
‘‘Trim Galore!.’’ The reads were then mapped against human hg19 using RNA STAR (Galaxy version 2.6.0b-1). Trimming, quality
control andmapping steps were conducted in the Galaxy platform (usegalaxy.org) (Afgan et al., 2018). To quantify expression countse3 Cell Reports 26, 3511–3521.e1–e4, March 26, 2019
of reads overlapping by one or more base calls, the gene annotationsmade by the procedure described above were calculated using
fjoin (Richardson, 2006) and a simple script to process the output of fjoin and associate counts to the gene IDs was also used. These
count tables were loaded into R and analyzed using the DESeq2 R package (Love et al., 2014). Differential expression was calculated
with DESeq2 standard settings. Heatmaps were generated following one of the default procedures described in the DESeq2manual.
Raw expression values were log-normalized (DESeq2 rlog function), each row was z-score normalized and genes were clustered by
the default hierarchical clustering used in the heatmap.2 function.
PAR-CLIP
The two replicates of PAR-CLIP of ZNF598 (Garzia et al., 2017) were retrieved from Sequence Read Archive (SRA: SRP095894).
Processing, mapping, normalization was done using the CLAP pipeline (Plass et al., 2017) and quantification of transcript binding
affinity done as described in (Hansen et al., 2015). The datasets were processed with custom python scripts to trim low-quality
base calls and remove 30adapters. A read was called as a duplication artifact of PCR if there was another read in the set of unique
reads with up to one base difference. For construction of the mapping index which was used in the mapping procedure of PAR-CLIP
libraries, a reference assembly for human, hg19 was retrieved from the UCSC table browser. As PAR-CLIP reads contain T positions
that are converted to C by the UV-radiation, this is accounted for in the substitution model in BWA-PSSM which assumes a conver-
sion rate of 12.5% and other parameters that deviated from default were set to -n 0.04 -l 1024 -m 400 -P 0.5. Finally reads with a
posterior probability of 0.99 or higher were called confidently mapped and those with a lower posterior probability multi-mappers.
For peak calling, normalization and quantification the Ensembl ver. 70 human annotation (Cunningham et al., 2015) was retrieved
from the Ensembl ftp-site and processed such that only the longest protein coding transcript for each genewas selected. Using these
gene models, respective annotations only containing exons, 30UTRs and coding regions were made. To call and use only significant
peaks, Pyicos (Althammer et al., 2011) was used with an annotation of exons, this method implements themodFDR (Xue et al., 2009).
Following this procedure PAR-CLIP clusters of each library were normalized to the total library size by calculation of per base reads
per million (RPM Equation 1).
ei =
106ci
N
(1)
Where ci is the number of base calls at position i and N is the total number of base calls of the confidently mapped CLIP reads in each
library. These quantities were summed along each mature transcript and divided by transcript length.
RNA electrophoretic mobility shift assay (REMSA)
Protein purification and REMSAwas performed as described before (Tiedje et al., 2012). In brief, Strep-tagged TTP and ZNF598were
expressed in HEK293T cells and purified using Strep-affinity beads (IBA Technologies, Germany). Elution of proteins with desthio-
biotin was followed by quantification in comparison to BSA standards andwas followed by quantification of band intensities using the
ImageJ software. According to these amounts the molarities of purified fusion proteins were calculated. For REMSAs, 400 fmol of a
50FAM-labeled IL-8 RNA oligo (Integrated DNA Technologies, IDT, USA), corresponding to the minimal TTP binding site in the 30UTR
of IL-8 (Winzen et al., 2007), was incubated with the indicated protein amounts on ice for 20 minutes. To test for binding to ARE and
polyA RNA stretches, 200 fmol of IRDye 700 and IRDye 800 50-labeled RNAs were used. Then loading buffer was added to the
samples that were consequently run on a pre-equilibrated 4% TBE polyacrylamide gel as described before (Tiedje et al., 2012).
50FAM samples were analyzed on a Bio-RadChemidoc Imaging System (Bio-Rad Laboratories, USA) or were scannedwith a LI-COR
Odyssey CLx device (LI-COR, USA) in case of IRDye-labeled probes. Band intensities were determined using ImageJ software. For
competition assays 4mg bacterial 16S and 23S rRNA was added per reaction (purchased from Roche #10206938001).
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical analyses were performedwith GraphPad PRISM7. Quantification of band intensities were carried out with the open source
software ImageJ (version 1.50i). The number of technical or biological replicates that were applied are given in the corresponding
figure legends. For relative mRNA level mean values ± standard deviations (SD) were calculated and significant changes were
determined by unpaired t tests.
DATA AND SOFTWARE AVAILABILITY
The RNaseq and differential expression data was deposited at the Gene Expression Omnibus (GEO) archive under the accession
number GSE116126.Cell Reports 26, 3511–3521.e1–e4, March 26, 2019 e4
